Market Pulse
Carillion contracts to be taken in-house or re-tendered, says government
Following the collapse of construction and outsourcing group Carillion, the government said it will take on some contracts and others will be re-tendered to other contractors.
FX round-up: US dollar slides to fresh 52-week low
The US dollar spot index continued to give back ground at the start of the week amid what analysts at UniCredit Research described as a "symphony of factors" conspiring to the advantage of the single currency.
JKX Oil and Gas completes workover of Ukrainian well
Upstream exploration and production company JKX Oil and Gas has successfully completed its workover project on its IG101Z well in Ukraine, the first drilling operation conducted by its local operator since 2015.
Broker tips: GKN, G4S, Johnson Matthey
Berenberg upped its price target on GKN to 455p from 365p on Monday, sticking with its 'buy' rating as it said it seems inevitable the engineer will end up being owned by Melrose Industries, after it rejected a £7bn bid last week.
Director dealings: Xafinity director buys £120,000 shares after acquisition
John Batting, executive director of pensions consulting and administration business Xafinity, forked out more than £121,000 on Monday to pick up shares.
Orosur Mining profits offset by depreciation and retrenchment costs
South-American focussed gold producer Orosur Mining produced a loss in the three months leading to 31 December, as growing operating profits were wiped out by higher levels of depreciation and costs associated to staff retrenchments.
Medical students are being urged to help relieve the NHS winter crisis
Undergraduates are voluntarily filling labour gaps at the NHS as it struggles to cope with the winter crisis.
Carclo directors depart alongside double profit warning
Shares in plastic components supplier Carclo tanked on Monday morning, as the West Yorkshire-based firm announced that its chairman and finance director had stood down after issuing a profit warning for last year and this.
Sinclair Pharma expects return to profit after revenues jump 20%
AIM-listed speciality pharmaceutical group Sinclair Pharma grew revenues by a fifth over the twelve months ended 31 December, as the effort put toward restructuring its European operations began to bear fruit.
Tuesday preview: UK inflation update, Dunelm, Rio Tinto, Ophir to report
Tuesday will determine whether inflation has exceeded Bank of England of England governor Mark Carney's target for the second month in a row, while January's deluge of retail updates continues on Tuesday with Dunelm, Greggs and JD Sports.
SoftBank may sell 30% of telecoms arm in £13bn IPO
Japanese company SoftBank is studying floating 30% of its mobile phone business SoftBank Corp. in Tokyo and overseas, possibly in the autumn.
FTSE 100 movers: GKN rises on bid speculation; JMAT gains on upgrade
London's FTSE 100 was down 0. 1% to 7,774. 47 in afternoon trade on Monday, with sentiment undermined by the collapse of contractor Carillion.
Carillion put into liquidation after talks with government, lenders fail
Construction group Carillion will be put into liquidation after crisis talks with the government and creditors collapsed early on Monday.
'Air of inevitability' that GKN will be owned by Melrose, says Berenberg
Berenberg upped its price target on GKN to 455p from 365p on Monday, sticking with its 'buy' rating as it said it seems inevitable the engineer will end up being owned by Melrose Industries, after it rejected a £7bn bid last week.
Velocys shares plummet as firm proposes fundraising
Waste-to-fuel company Velocys announced on Monday that it intended to raise around £18. 4m before expenses by way of a firm placing and open offer to fund initial development costs for two key projects.
Falanx wins new contract, appoints Ian Selby as CFO
Intelligence, security and cyber defence provider Falanx Group said on Monday that it has won a multi-year contract with a "premier" UK health sector organisation as it announced the appointment of a new chief financial officer.
Avacta reaches licensing agreement with Glythera after initial study yields positive results
Biotechnology company Avacta Group has successfully concluded its initial study with next-generation antibody drug conjugates developer Glythera, leading to a licensing agreement between the two firms.
Citi upgrades G4S to 'buy'
Citi upgraded its view on G4S stock to 'buy', pointing to an acceleration in organic growth, cost savings, benefits from re-financing and the possibility that the company might benefit from consolidation in its sector.
Europe midday: Stocks off lows despite renewed gains for euro
Stocks are trading on a mixed note, but off their worst levels, even as the single currency continues to gain altitude at a brisk clip.
Melrose begins shareholder meetings to discuss GKN proposal
Melrose Industries, whose £7bn offer for engineering group GKN was rejected last week, said on Monday that it is beginning a series of shareholder meetings to discuss the proposal.